News Briefs: August 5, 2019
FDA Warns CBD May Overpromise and Underdeliver The FDA’s recent warning to CuraLeaf regarding unsubstantiated medical claims about CBD’s health benefits spotlights an ongoing issue about CBD products: Many claims about CBD-based treatments are unproven. While CBD products have proliferated and experts agree there seems to be little direct risk to using CBD, consumers should…
